TR30 30mg*10vials

Tirzepatide TR30 30mg*10vials

Tirzepatide is a dual GLP-1 and GIP receptor agonist peptide, representing a high-concentration metabolic research compound that activates two gut hormone pathways simultaneously.

The 30mg single-vial specification delivers a substantial active ingredient load per vial. This formulation is designed for ultra-long-term large animal studies, high-dose efficacy validation experiments, and large-scale multi-group parallel research projects. The high concentration per vial minimizes the number of vials required for extended experimental timelines, effectively reducing data variability and operational errors from repeated dilution and solution preparation.

Through combined GLP-1 and GIP receptor activation, this compound supports advanced research into insulin sensitivity, glycemic regulation, appetite-related signaling, and metabolic homeostasis. The dual pathway approach provides a comprehensive scope for studying systemic metabolic regulation across large-scale experimental designs.

This product is supplied as sterile lyophilized powder in glass vials, formulated for reconstitution with bacteriostatic water. Each batch undergoes comprehensive purity testing, with a full certificate of analysis provided.

10 vials per pack, designed for large-scale preclinical research and extended dual-pathway metabolic projects.